These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26507065)

  • 1. [Erythema after subcutaneous heparin treatment].
    Brouns AJ; Jie KS
    Ned Tijdschr Geneeskd; 2015; 159():A9304. PubMed ID: 26507065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrater agreement for two systems used to determine the probability of heparin-induced thrombocytopenia.
    Doré M; Frenette AJ; Chagnon I; Routhier N; Williamson D
    Am J Health Syst Pharm; 2014 Dec; 71(23):2045-52. PubMed ID: 25404596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
    Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
    Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin-induced thrombocytopenia in a child.
    Dager WE; White RH
    Ann Pharmacother; 2004 Feb; 38(2):247-50. PubMed ID: 14742760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Levels of antiplatelet factor 4-heparin antibodies and 4T score for heparin induced thrombocytopenia].
    Martinuzzo ME; Cerrato GS; Iglesias Varela ML; Adamczuk YP; Pombo G; Forastiero RR
    Medicina (B Aires); 2012; 72(1):19-22. PubMed ID: 22257451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of heparin-induced thrombocytopenia with fondaparinux.
    Harenberg J; Jörg I; Fenyvesi T
    Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome.
    Tawfik NM; Hegazy MA; Hassan EA; Ramadan YK; Nasr AS
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):701-5. PubMed ID: 22008905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
    Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
    Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial thrombosis due to heparin induced thrombocytopenia].
    Klinkert LC; van Leeuwen DG; Brouwers AJ; van der Klooster JM
    Ned Tijdschr Geneeskd; 2013; 157(39):A6237. PubMed ID: 24063671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
    Gleichgerrcht E; Lim MY; Turan TN
    Neurologist; 2017 Nov; 22(6):241-244. PubMed ID: 29095327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia treated with fondaparinux: single center experience.
    Dulicek P; Ivanova E; Kostal M; Fiedlerova Z; Sadilek P; Hirmerova J
    Int Angiol; 2020 Feb; 39(1):76-81. PubMed ID: 31782283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
    Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
    Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
    Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Screening Scores for Heparin- Induced Thrombocytopenia After Cardiopulmonary Bypass.
    Cutler NS; Marchant BE
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3570-3575. PubMed ID: 35729026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.